JOURNAL BROWSE
Search
Advanced SearchSearch Tips
SETDB1 mediated FosB expression increases the cell proliferation rate during anticancer drug therapy
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
  • Journal title : BMB Reports
  • Volume 49, Issue 4,  2016, pp.238-243
  • Publisher : Korean Society for Biochemistry and Molecular Biology
  • DOI : 10.5483/BMBRep.2016.49.4.031
 Title & Authors
SETDB1 mediated FosB expression increases the cell proliferation rate during anticancer drug therapy
Na, Han-Heom; Noh, Hee-Jung; Cheong, Hyang-Min; Kang, Yoonsung; Kim, Keun-Cheol;
  PDF(new window)
 Abstract
The efficacy of anticancer drugs depends on a variety of signaling pathways, which can be positively or negatively regulated. In this study, we show that SETDB1 HMTase is down-regulated at the transcriptional level by several anticancer drugs, due to its inherent instability. Using RNA sequence analysis, we identified FosB as being regulated by SETDB1 during anticancer drug therapy. FosB expression was increased by treatment with doxorubicin, taxol and siSETDB1. Moreover, FosB was associated with an increased rate of proliferation. Combinatory transfection of siFosB and siSETDB1 was slightly increased compared to transfection of siFosB. Furthermore, FosB was regulated by multiple kinase pathways. ChIP analysis showed that SETDB1 and H3K9me3 interact with a specific region of the FosB promoter. These results suggest that SETDB1-mediated FosB expression is a common molecular phenomenon, and might be a novel pathway responsible for the increase in cell proliferation that frequently occurs during anticancer drug therapy.
 Keywords
Anticancer drugs;Doxorubicin;Drug resistance;FosB;SETDB1;
 Language
English
 Cited by
 References
1.
Giussani P, Tringali C, Riboni L, Viani P and Venerando B (2014) Sphingolipids: key regulators of apoptosis and pivotal players in cancer drug resistance. Int J Mol Sci 15, 4356-4392 crossref(new window)

2.
Yang W, Park IJ, Yun H et al (2014) AMP-activated protein kinase alpha2 and E2F1 transcription factor mediate doxorubicin-induced cytotoxicity by forming a positive signal loop in mouse embryonic fibroblasts and non-carcinoma cells. J Biol Chem 289, 4839-4852 crossref(new window)

3.
Korbakis D and Scorilas A (2012) Quantitative expression analysis of the apoptosis-related genes BCL2, BAX and BCL2L12 in gastric adenocarcinoma cells following treatment with the anticancer drugs cisplatin, etoposide and taxol. Tumour Biol 33, 865-875 crossref(new window)

4.
Choi YH and Yoo YH (2012) Taxol-induced growth arrest and apoptosis is associated with the upregulation of the Cdk inhibitor, p21WAF1/CIP1, in human breast cancer cells. Oncol Rep 28, 2163-2169

5.
Liu Z, Zhu G, Getzenberg RH and Veltri RW (2015) The Upregulation of PI3K/Akt and MAP Kinase Pathways is Associated with Resistance of Microtubule-Targeting Drugs in Prostate Cancer. J Cell Biochem 116, 1341-1349 crossref(new window)

6.
Jung KA, Choi BH and Kwak MK (2015) The c-MET/PI3K signaling is associated with cancer resistance to doxorubicin and photodynamic therapy by elevating BCRP/ABCG2 expression. Mol Pharmacol 87, 465-476 crossref(new window)

7.
Guetg C and Santoro R (2012) Formation of nuclear heterochromatin: the nucleolar point of view. Epigenetics 7, 811-814 crossref(new window)

8.
Meier K and Brehm A (2014) Chromatin regulation: how complex does it get? Epigenetics 9, 1485-1495 crossref(new window)

9.
Kamiunten T, Ideno H, Shimada A et al (2015) Coordinated expression of H3K9 histone methyltransferases during tooth development in mice. Histochem Cell Biol 143, 259-266 crossref(new window)

10.
Zhang Y and Tong T (2014) FOXA1 antagonizes EZH2-mediated CDKN2A repression in carcinogenesis. Biochem Biophys Res Commun 453, 172-178 crossref(new window)

11.
Ayrapetov MK, Gursoy-Yuzugullu O, Xu C, Xu Y and Price BD (2014) DNA double-strand breaks promote methylation of histone H3 on lysine 9 and transient formation of repressive chromatin. Proc Natl Acad Sci U S A 111, 9169-9174 crossref(new window)

12.
Zhang J, Taylor RJ, La Torre A et al (2015) Ezh2 maintains retinal progenitor proliferation, transcriptional integrity, and the timing of late differentiation. Dev Biol 403, 128-138 crossref(new window)

13.
Song YJ, Choi JH and Lee H (2015) Setdb1 is required for myogenic differentiation of C2C12 myoblast cells via maintenance of MyoD expression. Mol Cells 38, 362-372 crossref(new window)

14.
Thompson PJ, Dulberg V, Moon KM et al (2015) hnRNP K coordinates transcriptional silencing by SETDB1 in embryonic stem cells. PLoS Genet 11, e1004933 crossref(new window)

15.
Schultz DC, Ayyanathan K, Negorev D, Maul GG and Rauscher FJ (2002) SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. Genes Dev 16, 919-932 crossref(new window)

16.
Wu PC, Lu JW, Yang JY et al (2014) H3K9 histone methyltransferase, KMT1E/SETDB1, cooperates with the SMAD2/3 pathway to suppress lung cancer metastasis. Cancer Res 74, 7333-7343 crossref(new window)

17.
Lee JK and Kim KC (2013) DZNep, inhibitor of S-adenosylhomocysteine hydrolase, down-regulates expression of SETDB1 H3K9me3 HMTase in human lung cancer cells. Biochem Biophys Res Commun 438, 647-652 crossref(new window)

18.
Noh HJ, Kim KA and Kim KC (2014) p53 down-regulates SETDB1 gene expression during paclitaxel induced-cell death. Biochem Biophys Res Commun 446, 43-48 crossref(new window)

19.
Ceol CJ, Houvras Y, Jane-Valbuena J et al (2011) The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset. Nature 471, 513-517 crossref(new window)

20.
Rodriguez-Paredes M, Martinez de Paz A, Simo-Riudalbas L et al (2014) Gene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis. Oncogene 33, 2807-2813 crossref(new window)

21.
Wakabayashi Y, Tamiya T, Takada I et al (2011) Histone 3 lysine 9 (H3K9) methyltransferase recruitment to the interleukin-2 (IL-2) promoter is a mechanism of suppression of IL-2 transcription by the transforming growth factor-beta-Smad pathway. J Biol Chem 286, 35456-35465 crossref(new window)

22.
Martin FJ, Xu Y, Lohmann F et al (2015) KMT1E-mediated chromatin modifications at the FcgammaRIIb promoter regulate thymocyte development. Genes Immun 16, 162-169 crossref(new window)

23.
Ramachandran A, Gong EM, Pelton K et al (2011) FosB regulates stretch-induced expression of extracellular matrix proteins in smooth muscle. Am J Pathol 179, 2977-2989 crossref(new window)

24.
Ratajczak-Wrona W, Jablonska E, Garley M et al (2014) PI3K-Akt/PKB signaling pathway in neutrophils and mononuclear cells exposed to N-nitrosodimethylamine. J Immunotoxicol 11, 231-237 crossref(new window)

25.
Win-Shwe TT and Fujimaki H (2015) Activation of transcription factors in a mouse lung following exposure to environmental chemical and biological agents. J Toxicol Sci 40, 559-568 crossref(new window)

26.
Hong S, Skaist AM, Wheelan SJ and Friedman AD (2011) AP-1 protein induction during monopoiesis favors C/EBP: AP-1 heterodimers over C/EBP homodimerization and stimulates FosB transcription. J Leukoc Biol 90, 643-651 crossref(new window)

27.
Lazenka MF, David BG, Lichtman AH, Nestler EJ, Selley DE and Sim-Selley LJ (2014) Delta FosB and AP-1-mediated transcription modulate cannabinoid CB(1) receptor signaling and desensitization in striatal and limbic brain regions. Biochem Pharmacol 91, 380-389 crossref(new window)

28.
Ruffle JK (2014) Molecular neurobiology of addiction: what's all the (Delta)FosB about? Am J Drug Alcohol Abuse 40, 428-437 crossref(new window)

29.
Vialou V, Thibault M, Kaska S et al (2015) Differential induction of FosB isoforms throughout the brain by fluoxetine and chronic stress. Neuropharmacology 99, 28-37 crossref(new window)

30.
Bunjobpol W, Dulloo I, Igarashi K, Concin N, Matsuo K and Sabapathy K (2014) Suppression of acetylpolyamine oxidase by selected AP-1 members regulates DNp73 abundance: mechanistic insights for overcoming DNp73-mediated resistance to chemotherapeutic drugs. Cell Death Differ 21, 1240-1249 crossref(new window)

31.
Spyropoulou A, Gargalionis A, Dalagiorgou G et al (2014) Role of histone lysine methyltransferases SUV39H1 and SETDB1 in gliomagenesis: modulation of cell proliferation, migration, and colony formation. Neuromolecular Med 16, 70-82 crossref(new window)

32.
Pallante P, Sepe R, Federico A, Forzati F, Bianco M and Fusco A (2014) CBX7 modulates the expression of genes critical for cancer progression. PLoS One 9, e98295 crossref(new window)

33.
Scott CL, Gil J, Hernando E et al (2007) Role of the chromobox protein CBX7 in lymphomagenesis. Proc Nat Acad Sci U S A 104, 5389-5394 crossref(new window)

34.
Im CN, and Seo JS (2014) Overexpression of tumor necrosis factor receptor-associated protein 1 (TRAP1), leads to mitochondrial aberrations in mouse fibroblast NIH/3T3 cells. BMB Rep 47, 280-285 crossref(new window)

35.
Shang Y, Hu X, DiRenzo J, Lazar MA and Brown M (2000) Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103, 843-852 crossref(new window)